{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:28:27Z","timestamp":1777566507555,"version":"3.51.4"},"reference-count":41,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2017,1,2]]},"DOI":"10.1080\/14728214.2017.1293651","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T16:01:37Z","timestamp":1486656097000},"page":"101-105","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer\u2019s disease"],"prefix":"10.1080","volume":"22","author":[{"given":"Amanda","family":"Calhoun","sequence":"first","affiliation":[{"name":"Department of Psychiatry &amp; Behavioral Neuroscience, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Psychiatry &amp; Behavioral Neuroscience, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George T.","family":"Grossberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry &amp; Behavioral Neuroscience, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828726f5"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.03.001"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.09.069"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2015.09.007"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.09.007"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2008.05.008"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","volume":"41","author":"Tan CC","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001190.pub2"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-5-200803040-00009"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16499-4"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.11.005"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.03.043"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuropharm.2016.09.017","volume":"113","author":"Amat-Foraster M","year":"2016","journal-title":"Neuropharmacology"},{"key":"CIT0016","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"Serrano-Pozo A","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181919a48"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.041616"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2-6"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00439-C"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","volume":"43","author":"Monsma FJ","year":"1993","journal-title":"Mol Pharmacol"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1076\/anec.6.3.229.777"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.06.033"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00056-9"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702445"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.2.137"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(98)01361-7"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.281"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02022.x"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703288"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00265-2"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb13381.x"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1006\/neur.1996.0051"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.2174\/1568007043482561"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301503"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01224-3"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.995168"},{"key":"CIT0041","doi-asserted-by":"crossref","unstructured":"Lundbeck provides update on Phase 3 Study for Alzheimer\u2019s treatment. Drug Discov Dev. 2016; Available at http:\/\/www.dddmag.com\/news\/2016\/09\/lundbeck-provides-update-phase-3-study-alzheimers-treatment [Last accessed 1 December 2016].","DOI":"10.1016\/S0958-2118(16)30117-3"},{"key":"CIT0043","unstructured":"Suven Inc, Suven Life Sciences. A phase 2a multicenter, randomized, double-Blind, parallel group, 26-week, placebo-controlled study of SUVN-502 in subjects with moderate Alzheimer\u2019s disease currently treated with onepezil hydrochloride and memantine hydrochloride. ClinicalTrials.gov. [Internet]. Cited November 2016. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02580305 NLM identifier: NCT02580305."},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-015-9736-3"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2017.1293651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T05:18:25Z","timestamp":1749964705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2017.1293651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,22]]},"published-print":{"date-parts":[[2017,1,2]]}},"alternative-id":["10.1080\/14728214.2017.1293651"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2017.1293651","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}